A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of SAR444336 in participants with microscopic colitis in clinical remission with budesonide. (ACT18053)

Principal Investigator

Dr Michael Fitzpatrick

Contact us

Email: ctf.research@ouh.nhs.uk

IRAS number

1011540